Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Maternal Marker Alpha Fetoprotein (AFP) is 7 days.

What are the prerequisites for the test Maternal Marker Alpha Fetoprotein (AFP)

  • Blood sample
  • No special preparation required
  • Inform the healthcare provider about any medications or supplements being taken
  • Inform the healthcare provider about any existing medical conditions

What are the measure values for the test Maternal Marker Alpha Fetoprotein (AFP)

  • Normal range for AFP in pregnant women: 10-100 ng/mL
  • Abnormal range for AFP in pregnant women: >100 ng/mL

What does this test Maternal Marker Alpha Fetoprotein (AFP) identify?

Maternal Marker Alpha Fetoprotein (AFP)

This test measures the level of Alpha Fetoprotein (AFP) in a pregnant woman's blood. AFP is a protein produced by the fetus and is found in the mother's blood during pregnancy. Elevated levels of AFP can indicate certain birth defects, such as neural tube defects or abdominal wall defects, in the developing fetus. It can also be a marker for other conditions, such as liver disease or certain cancers.

Why is this test Maternal Marker Alpha Fetoprotein (AFP) taken?

The Maternal Marker Alpha Fetoprotein (AFP) test is taken during pregnancy to screen for certain birth defects, such as neural tube defects (spina bifida) or chromosomal abnormalities (Down syndrome). AFP is a protein produced by the baby's liver that can be detected in the mother's blood. Abnormal levels of AFP may indicate a potential problem with the baby's development.

Popular FAQs on Test

Maternal Marker Alpha Fetoprotein (AFP) test is a blood test that measures the level of AFP in a pregnant woman's blood. AFP is a protein produced by the baby's liver that can indicate the risk of certain birth defects or chromosomal abnormalities.
The Maternal Marker Alpha Fetoprotein (AFP) test is typically done between 15 and 20 weeks of pregnancy. It is part of the routine prenatal screening tests to assess the risk of neural tube defects such as spina bifida and anencephaly.
The Maternal Marker Alpha Fetoprotein (AFP) test involves a simple blood draw from the pregnant woman. The blood sample is then sent to a laboratory for analysis to determine the AFP levels.
Abnormal results of the Maternal Marker Alpha Fetoprotein (AFP) test can indicate a higher risk of neural tube defects, such as spina bifida or anencephaly, or chromosomal abnormalities, such as Down syndrome. However, it is important to note that abnormal results do not definitively diagnose these conditions and further testing may be needed.
No, the Maternal Marker Alpha Fetoprotein (AFP) test is not used to determine the gender of the baby. It is specifically used to assess the risk of certain birth defects and chromosomal abnormalities.

Customer Google Rating